Fresenius Medical Care AG & Co. KGAA (ETR:FME) has been given a €85.00 ($100.00) price objective by equities research analysts at HSBC Holdings PLC in a report released on Wednesday. The brokerage presently has a “neutral” rating on the stock. HSBC Holdings PLC’s target price points to a potential upside of 2.78% from the stock’s current price.

A number of other research analysts have also recently issued reports on FME. Berenberg Bank set a €92.10 ($108.35) target price on Fresenius Medical Care AG & Co. KGAA and gave the company a “buy” rating in a research report on Wednesday, July 26th. J P Morgan Chase & Co set a €106.40 ($125.18) target price on Fresenius Medical Care AG & Co. KGAA and gave the company a “buy” rating in a research report on Thursday, July 27th. UBS AG set a €68.00 ($80.00) target price on Fresenius Medical Care AG & Co. KGAA and gave the company a “sell” rating in a research report on Tuesday, August 1st. Commerzbank Ag set a €88.00 ($103.53) target price on Fresenius Medical Care AG & Co. KGAA and gave the company a “neutral” rating in a research report on Tuesday, August 1st. Finally, S&P Global set a €95.00 ($111.76) target price on Fresenius Medical Care AG & Co. KGAA and gave the company a “buy” rating in a research report on Tuesday, August 1st. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and ten have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of €89.05 ($104.77).

Fresenius Medical Care AG & Co. KGAA (ETR:FME) traded down €0.88 ($1.04) during trading on Wednesday, reaching €82.70 ($97.29). The company’s stock had a trading volume of 439,251 shares, compared to its average volume of 552,386. Fresenius Medical Care AG & Co. KGAA has a 1 year low of €71.49 ($84.11) and a 1 year high of €89.22 ($104.96).

ILLEGAL ACTIVITY NOTICE: “Fresenius Medical Care AG & Co. KGAA (FME) Given a €85.00 Price Target at HSBC Holdings PLC” was first published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright and trademark law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/22/fresenius-medical-care-ag-85-00-price-target-at-hsbc-holdings-plc.html.

About Fresenius Medical Care AG & Co. KGAA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGAA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGAA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGAA and related companies with MarketBeat.com's FREE daily email newsletter.